Palisade Bio (PALI) Depreciation & Amortization (IS) (2010 - 2014)
Palisade Bio (PALI) reported Depreciation & Amortization (IS) of $88409.0 for Q4 2014, up 40.93% year-over-year from $62734.0 in Q4 2013, and up 6.52% on a QoQ basis from $83001.0 in Q3 2014.
Palisade Bio (PALI) has 5 years of Depreciation & Amortization (IS) data on file, last reported at $88409.0 in Q4 2014.
- Quarterly Depreciation & Amortization (IS) rose 40.93% year-over-year to $88409.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $348630.0 (up 42.46% YoY) and the FY2014 annual result came in at $348630.0, up 42.46% from the prior year.
- Depreciation & Amortization (IS) rose to $88409.0 in Q4 2014 per PALI's latest filing, from $83001.0 in the prior quarter.
- Across five years, Depreciation & Amortization (IS) topped out at $90488.0 in Q1 2014 and bottomed at $25293.0 in Q1 2011.
- The 5-year median for Depreciation & Amortization (IS) is $50505.0 (2013), against an average of $57538.8.
- The widest annual swing landed in 2011, when Depreciation & Amortization (IS) surged 95.98%; it then plunged 31.13% in 2012.
- Tracing PALI's Depreciation & Amortization (IS) over 5 years: stood at $28755.0 in 2010, then surged by 30.42% to $37502.0 in 2011, then grew by 25.3% to $46989.0 in 2012, then jumped by 33.51% to $62734.0 in 2013, then surged by 40.93% to $88409.0 in 2014.
- Per Business Quant, the three latest PALI Depreciation & Amortization (IS) figures stand at $88409.0 (Q4 2014), $83001.0 (Q3 2014), and $86732.0 (Q2 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 127,436.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 88,409.00 |
| Sep 30, 2014 | 83,001.00 |
| Jun 30, 2014 | 86,732.00 |
| Mar 31, 2014 | 90,488.00 |
| Dec 31, 2013 | 62,734.00 |
| Sep 30, 2013 | 81,393.00 |
| Jun 30, 2013 | 50,505.00 |
| Mar 31, 2013 | 50,093.00 |
| Dec 31, 2012 | 46,989.00 |
| Sep 30, 2012 | 87,908.00 |
| Jun 30, 2012 | 41,300.00 |
| Mar 31, 2012 | 34,946.00 |
| Dec 31, 2011 | 37,502.00 |
| Sep 30, 2011 | 64,285.00 |
| Jun 30, 2011 | 59,971.00 |
| Mar 31, 2011 | 25,293.00 |
| Dec 31, 2010 | 28,755.00 |
| Sep 30, 2010 | 42,333.00 |
| Jun 30, 2010 | 30,601.00 |